| Dr Christina Gale Loporcaro, MD | |
|
250 Pleasant St, Concord, NH 03301-2598 | |
| (603) 225-2711 | |
| (603) 224-6527 |
| Full Name | Dr Christina Gale Loporcaro |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 8 Years |
| Location | 250 Pleasant St, Concord, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063862944 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 19533 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Concord Hospital | Concord, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Concord Hospital Inc | 6103721790 | 462 |
News Archive
Orexigen Therapeutics, Inc. today announced that it has reached agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment for the Contrave outcomes trial.
Federal officials are happy with what may turn out to be a soft launch of the health law's insurance exchanges Oct. 1. In the meantime, states are busy readying consumers for the exchanges' kickoffs with informational sessions and campaigns designed at creating a better-informed public.
CCN5, a matricellular protein, has been found to reverse established cardiac fibrosis in heart failure models, according to a study led by Roger J. Hajjar, MD, Professor of Medicine and Director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai, and Woo Jin Park, PhD, Professor of Life Sciences at the Gwangju Institute of Science and Technology, South Korea.
Results of a study in mice by researchers at the University of California, San Diego strongly suggest that the protein kinase JNK1 plays a key role in the development of retinopathy in premature infants.
› Verified 9 days ago
| Entity Name | Concord Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194778571 PECOS PAC ID: 6103721790 Enrollment ID: O20040405000916 |
News Archive
Orexigen Therapeutics, Inc. today announced that it has reached agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment for the Contrave outcomes trial.
Federal officials are happy with what may turn out to be a soft launch of the health law's insurance exchanges Oct. 1. In the meantime, states are busy readying consumers for the exchanges' kickoffs with informational sessions and campaigns designed at creating a better-informed public.
CCN5, a matricellular protein, has been found to reverse established cardiac fibrosis in heart failure models, according to a study led by Roger J. Hajjar, MD, Professor of Medicine and Director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai, and Woo Jin Park, PhD, Professor of Life Sciences at the Gwangju Institute of Science and Technology, South Korea.
Results of a study in mice by researchers at the University of California, San Diego strongly suggest that the protein kinase JNK1 plays a key role in the development of retinopathy in premature infants.
› Verified 9 days ago
| Entity Name | Concord Hospital-laconia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053993741 PECOS PAC ID: 7012326259 Enrollment ID: O20210429001355 |
News Archive
Orexigen Therapeutics, Inc. today announced that it has reached agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment for the Contrave outcomes trial.
Federal officials are happy with what may turn out to be a soft launch of the health law's insurance exchanges Oct. 1. In the meantime, states are busy readying consumers for the exchanges' kickoffs with informational sessions and campaigns designed at creating a better-informed public.
CCN5, a matricellular protein, has been found to reverse established cardiac fibrosis in heart failure models, according to a study led by Roger J. Hajjar, MD, Professor of Medicine and Director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai, and Woo Jin Park, PhD, Professor of Life Sciences at the Gwangju Institute of Science and Technology, South Korea.
Results of a study in mice by researchers at the University of California, San Diego strongly suggest that the protein kinase JNK1 plays a key role in the development of retinopathy in premature infants.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christina Gale Loporcaro, MD 250 Pleasant St, Concord, NH 03301-2598 Ph: (603) 225-2711 | Dr Christina Gale Loporcaro, MD 250 Pleasant St, Concord, NH 03301-2598 Ph: (603) 225-2711 |
News Archive
Orexigen Therapeutics, Inc. today announced that it has reached agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment for the Contrave outcomes trial.
Federal officials are happy with what may turn out to be a soft launch of the health law's insurance exchanges Oct. 1. In the meantime, states are busy readying consumers for the exchanges' kickoffs with informational sessions and campaigns designed at creating a better-informed public.
CCN5, a matricellular protein, has been found to reverse established cardiac fibrosis in heart failure models, according to a study led by Roger J. Hajjar, MD, Professor of Medicine and Director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai, and Woo Jin Park, PhD, Professor of Life Sciences at the Gwangju Institute of Science and Technology, South Korea.
Results of a study in mice by researchers at the University of California, San Diego strongly suggest that the protein kinase JNK1 plays a key role in the development of retinopathy in premature infants.
› Verified 9 days ago
Miss Kelsey Rainie, ATC, LAT Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 Avon St, Concord, NH 03301 Phone: 603-848-1859 | |
Zea Larochelle, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-227-7000 Fax: 603-230-7218 | |
Ryan J. Sault, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-225-2711 Fax: 603-224-6527 | |
Dr. Jeremy Semeiks, M.D. PH.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-225-2711 Fax: 603-224-6527 | |
Shayna J. Carp, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-225-2711 Fax: 603-224-6527 | |
Dr. Fred P. Dutton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant Street, Emergency Department, Concord, NH 03301 Phone: 603-225-2711 Fax: 603-224-6527 |